TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
TherapeuticsMD, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$1.86−0.04 (-2.11%)
Close on Oct 19, 2026
- Market cap
- $21.66M
- P/E (TTM)
- –
- Dividend yield
- –
TherapeuticsMD, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prescription Vitamins [Member] | – | – | – | – | $5.73M | $9.77M | $9.89M | $15.04M | $16.74M | $18.85M | – | – |
| OTC Products [Member] | – | – | – | – | – | – | – | – | $32.88K | $501.47K | – | – |
| Product [Member] | – | – | – | – | $85.78M | $62.87M | $34.14M | $16.10M | $16.78M | – | – | – |
| IMVEXXY [Member] | – | – | – | – | – | – | – | $1.06M | – | – | – | – |
| IMVEXXY [Member] | – | – | – | – | $31.53M | $27.14M | $16.25M | $1.06M | – | – | – | – |
| License and service revenue | – | – | – | – | – | – | $15.51M | – | – | – | – | – |
| BIJUVA [Member] | – | – | – | – | $10.58M | $6.35M | $1.84M | – | – | – | – | – |
| ANNOVERA [Member] | – | – | – | – | $37.94M | $19.61M | $6.17M | – | – | – | – | – |
| License and service revenue | – | – | $1.30M | $69.96M | $2.57M | $2.00M | $15.51M | – | – | – | – | – |
| Theramex [Member] | – | – | – | $1.40M | $2.57M | – | – | – | – | – | – | – |
| Mayne Pharma [Member] | – | – | – | $68.56M | – | – | – | – | – | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $1.79M | $1.12M | $1.00M | – | – | – | – | – | – | – | 59.3% | +59.6% |
| Non-U.S. [Member] | $1.23M | $638.00K | $299.00K | – | – | – | – | – | – | – | 40.7% | +92.8% |
From the segment and revenue-disaggregation notes of TherapeuticsMD's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.